The promise of cell-based therapies for diabetic complications: challenges and solutions
about
Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic HypertensionDifferent sources of autologous mononuclear cells and stem cells for critical lower limb ischaemiaStem Cells for Cutaneous Wound HealingAutologous bone marrow cell therapy for peripheral arterial diseaseRegenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathyEpisodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cellsThe dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetesDipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cellsPoor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation.Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3.Cell-based therapies for diabetic complications.The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord bloodCombination therapy accelerates diabetic wound closure.Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms.Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability.An in vitro study of differentiation of hematopoietic cells to endothelial cellsAdenosine accelerates the healing of diabetic ischemic ulcers by improving autophagy of endothelial progenitor cells grown on a biomaterial.ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.Impaired Mobilization of Vascular Reparative Bone Marrow Cells in Streptozotocin-Induced Diabetes but not in Leptin Receptor-Deficient db/db Mice.miR-92a Corrects CD34+ Cell Dysfunction in Diabetes by Modulating Core Circadian Genes Involved in Progenitor DifferentiationPreconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureOxidative stress-mediated thrombospondin-2 upregulation impairs bone marrow-derived angiogenic cell function in diabetes mellitusTargeting the endothelial progenitor cell surface proteome to identify novel mechanisms that mediate angiogenic efficacy in a rodent model of vascular disease.Diabetic Retinopathy: Battling the Global Epidemic.20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.Glycogen synthase kinase-3β and cathepsin B in diabetic endothelial progenitor cell dysfunction: an old player finds a new partner.Mesenchymal stem cells: new players in retinopathy therapy.Cell-based therapies for diabetic retinopathy.Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy.Free radical biology of the cardiovascular system.Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.Stem cell therapies in the treatment of diabetic retinopathy and keratopathy.Stem Cells for Diabetes Complications: A Future Potential Cure.Stem cells and diabetic cardiomyopathy: from pathology to therapy.Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality.Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3.
P2860
Q22306336-81404065-C7BA-425A-9C0E-67708A1F040DQ24198835-D3AE313D-D247-4B38-8965-2CF43BD81FC3Q27025609-402B41B4-E519-4561-B135-B91CBBE99800Q27026719-209739E5-6367-4436-A31C-8828F637F888Q27334841-33791A25-0DD6-473F-8131-2499D5398368Q28749217-B5F2A7E0-EBE3-4CBF-90D1-25797BDEBEC1Q33562214-33DABB5B-830B-48F5-AFA6-9C9C740D36A0Q33719419-FA37BB77-6F1C-4DDA-9591-A004BA033572Q34111573-005EE52D-3E78-445B-815F-AAAC66B6F5EFQ34334364-6F2373E1-97D0-4155-8568-7A49352F5D4BQ34446306-876DB4B1-3C6A-4CF4-B858-92609B61BDCEQ34849698-10A2DB6D-2520-4E36-B2D3-2A9D293469BFQ35070554-0F35018E-F7D4-462E-8E8F-E4E847FD94F1Q35122891-54DB2A5F-80E9-4142-83AD-4C4D51318840Q35126527-E814783D-9125-4B97-828D-6C7722B14199Q35142725-1A3280B9-7F0B-452C-A7E0-BA21A3D0882BQ35204126-24449A1E-B36B-4923-98F6-F7438D93B06FQ35661522-BC221611-E0F4-4A73-9CA8-5CFA30DFB48DQ35778352-32103F2B-B5D7-4959-9BF1-9A809122E11BQ36339485-87B6C0AE-8CA7-411C-AA44-14A95A47D299Q36910839-4FD13B20-0374-4B4E-BCA0-63CB20421557Q36926378-D32E22FB-528B-4800-A077-4E720754E443Q36998592-78D084CE-BC7F-4E4F-ACD6-9D5BD517FDD5Q37081415-337D4F6D-2938-48E6-B997-3BA0B408C079Q37133201-498BB8B5-A1D0-4E49-938E-63D156CCA149Q37346007-BAE37A38-9F86-44A3-BFAA-A92129FEF50CQ37494858-0EBDCC6C-C575-4B89-8749-752D9F4D4737Q37603893-FDFBDFDC-2DB8-40E7-B900-3EA2838138FAQ37660947-66F30D99-63B2-41EA-8F26-D503C6B413EAQ37734972-36637457-2D4B-4398-AFC6-446FA8777936Q37879584-27540179-A097-46CF-9300-906EBD79A930Q37921103-A2A860A9-C537-4C3E-8317-1F6BD39DE667Q37997802-A28FC7AE-28F8-4FD4-8825-19A86D6148B5Q38185249-628938DA-F9AE-4A06-AF89-58BBB297F277Q38603660-3A2044DE-2E29-4325-814C-D77A8C7C3718Q38759783-120564FA-77E7-420E-B191-EEDBBB0FDFF3Q38843402-CD6EAE7A-A861-40D9-972D-D4C2207B8032Q39148627-B0642BD3-E7B9-4531-9246-F18D836B80C1Q42181707-34F093DA-8ADB-4B63-8185-C805B164A778Q42223358-BBA774A3-C244-4785-8924-B48516A5DD19
P2860
The promise of cell-based therapies for diabetic complications: challenges and solutions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The promise of cell-based therapies for diabetic complications: challenges and solutions
@en
The promise of cell-based therapies for diabetic complications: challenges and solutions.
@nl
type
label
The promise of cell-based therapies for diabetic complications: challenges and solutions
@en
The promise of cell-based therapies for diabetic complications: challenges and solutions.
@nl
prefLabel
The promise of cell-based therapies for diabetic complications: challenges and solutions
@en
The promise of cell-based therapies for diabetic complications: challenges and solutions.
@nl
P2860
P1433
P1476
The promise of cell-based therapies for diabetic complications: challenges and solutions
@en
P2093
Maria B Grant
Yagna P R Jarajapu
P2860
P304
P356
10.1161/CIRCRESAHA.109.213140
P577
2010-03-01T00:00:00Z